IMCR

Immunocore Holdings Plc

• Simply Wall St·3d ago

  Immunocore (IMCR) Stock May Trade Above Fair Value On A 48% Slump

• NASDAQ·07/01 09:06

  AstraZeneca's Enhertu Wins EU Nod for HER2-Positive Solid Tumors (Revised)

• Simply Wall St·06/29 20:12

  Immunocore Holdings (IMCR) In Focus As Its Cash Backed Growth Narrative Shapes Valuation

• NASDAQ·06/26 14:43

  IONS Out-Licenses ex-U.S. Rights for Rare Neurology Drug to Recordati

• NASDAQ·06/26 14:34

  Here's Why You Should Add Kiniksa Stock to Your Portfolio Now

• Seeking Alpha·06/24 12:34

  Immunocore: KIMMTRAK Is Becoming A Cash Engine For A Much Larger TCR Platform

• NASDAQ·06/23 15:07

  NVO Gains as Foundation Unveils EUR 60M Cardiometabolic Research Push

• Simply Wall St·06/22 23:29

  How Investors May Respond To Immunocore (IMCR) Melanoma Data Highlighting Brenetafusp’s Potential In PD‑1‑Resistant Disease

• NASDAQ·06/19 18:19

  QURE Soars as FDA Backs AMT-130 Data for Accelerated Approval

• NASDAQ·06/19 14:35

  BEAM Stock Gains 5% as FDA Clears BEAM-304 IND for Phenylketonuria

• NASDAQ·06/19 14:24

  PFE Stock Slides Following CFO Exit, 2026 Guidance Reaffirmed

• NASDAQ·06/19 13:16

  Teva Seeks FDA Nod for Ecopipam in Pediatric Tourette Syndrome

• NASDAQ·06/19 12:14

  Can Vertex's Kidney Pipeline Power Its Next Growth Phase?

• Simply Wall St·06/18 21:39

  Immunocore Holdings (IMCR) Stock Could Be 57.1% Undervalued After Annual Results

• NASDAQ·06/17 10:47

  MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review (Revised)